Dupilumab treatment for prurigo nodularis: a retrospective study of 76 patients
Dupilumab effectively reduces the number of PN, improves IGA scores, alleviates pruritus, and enhances quality of life in patients with moderate to severe PN, with a high safety profile.
Authors
- Yan Zhao (ORCID: https://orcid.org/0000-0002-1638-7751)
- Congcong Gao (ORCID: https://orcid.org/0000-0003-1771-8847)
- Hong Leng
Institutions
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Advances in Dermatology and Allergology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/ada.2025.152080
- Citations
- 2
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.01